Cover |
Dec. 28, 2023 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | On January 4, 2024, ProPhase Labs, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) to report the appointment of Jed A. Latkin as Chief Operating Officer (the “Chief Operating Officer”) of the Company, effective as of January 1, 2024. This Amendment No. 1 on Form 8-K/A is being filed to supplement the disclosure contained in Item 5.02 of the Original Form 8-K and include a copy of the Inducement Option Award Agreement. The Original Form 8-K otherwise remains unchanged. |
| Document Period End Date | Dec. 28, 2023 |
| Entity File Number | 000-21617 |
| Entity Registrant Name | PROPHASE LABS, INC. |
| Entity Central Index Key | 0000868278 |
| Entity Tax Identification Number | 23-2577138 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 711 Stewart Avenue |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, City or Town | Garden City |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 11530 |
| City Area Code | (215) |
| Local Phone Number | 345-0919 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0005 |
| Trading Symbol | PRPH |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |